US Stocks
/
Indaptus Therapeutics, Inc. Share Price

Indaptus Therapeutics, Inc. Share Price

NASDAQ: INDP | Micro Cap
$1.15
-$0.02 (-1.71%) Last updated on 29 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Indaptus Therapeutics, Inc. Stock Performance

Open
$1.15
Prev. Close
$1.17
Circuit Range
N/A
Day Range
$1.15 - $1.16
Year Range
$0.92 - $8.44
Volume
1,765
Average Traded
$1.15

Indaptus Therapeutics, Inc. Share Price Today

As of 29 August 2026, Indaptus Therapeutics, Inc.'s share price is $1.15. The stock opened at $1.15, compared to its previous close of $1.17. During today's trading session, Indaptus Therapeutics, Inc.'s share price traded between $1.15 and $1.16, with an average price of $1.15. Over the past 52 weeks, the stock has recorded a high of $8.44 and a low of $0.92. In terms of performance, Indaptus Therapeutics, Inc.'s share price has declined by 41.33% over the last six months and is down 82.24% on a year-on-year basis.

Indaptus Therapeutics, Inc. Share Price Chart

$1.15$1.16
L
Show Current Price
H

Indaptus Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.11M
PE Ratio (TTM)
-0.05
Dividend Yield
N/A
EPS (TTM)
$-21.58
Revenue (TTM)
N/A
Return On Equity (TTM)
-661.54%
Profit Margin
N/A
Debt to Equity
1.95
Quarterly Earnings Growth YoY
3.06%

Indaptus Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$3.81M-$4.02M-$3.07M-$4.53M-$5.23M-$2.98M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A-5.48%23.57%-47.68%-15.37%43.10%

Indaptus Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
RevenueN/AN/AN/AN/AN/A
Net Profit-$7.71M-$14.32M-$15.42M-$15.02M-$20.85M
Net Profit MarginN/AN/AN/AN/AN/A
Income ChangeN/A-85.74%-7.68%2.60%-38.79%

About Indaptus Therapeutics, Inc.

Indaptus Therapeutics, Inc., a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.

Indaptus Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$1.39
$1.17
-7.87%
Jul 2026
$2.95
$1.27
-57.45%
Jun 2026
$1.86
$2.98
+68.64%
May 2026
$2.66
$1.77
-41.29%
Apr 2026
$1.77
$3.02
+65.66%
Mar 2026
$1.94
$1.82
-7.14%
Feb 2026
$2.12
$1.96
-11.31%
Jan 2026
$2.86
$2.21
-26.33%
Dec 2025
$2.16
$3.00
+39.53%
Nov 2025
$3.06
$2.15
-33.64%
Oct 2025
$3.27
$3.24
+11.72%
Sep 2025
$6.22
$2.90
-55.23%

INDP Share Price FAQs

What is Indaptus Therapeutics, Inc. share price today?

chevron-up
Indaptus Therapeutics, Inc. share price today is $1.15 as on August 29, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Indaptus Therapeutics, Inc. stock?

chevron-up
The 52 week high of Indaptus Therapeutics, Inc. stock is $8.44, while the 52 week low is $0.92 as of 29 Aug '26.

What is INDP's market capitalisation today?

chevron-up
INDP market capitalisation is $1.11M as of August 29, 2026, at 3:13 pm IST.

What is INDP's net income for the last quarter?

chevron-up
INDP's net income for the last quarter is -0.00B USD.

What is the 5 year returns of INDP?

chevron-up
The 5 year returns of INDP is -99.61% as on 29 Aug '26.

What is the high & low stock price of INDP today?

chevron-up
INDP stock price hit a high of $1.16 and low of $1.15 as of 29 Aug '26.

Can I buy INDP shares in India?

chevron-up
Yes. You can buy INDP in India by opening an international trading account.